Similar companies
| Company | Transaction Value | |
|---|---|---|
 |
OcugenOCGN |
-$4.6M |
 |
AmarinAMRN |
$1.7M |
 |
Gilead SciencesGILD |
-$233M |
 |
Anavex Life SciencesAVXL |
-$14M |
 |
Inovio PharmaceuticalsINO |
-$2.2M |
Insider Transactions
| Name | Transaction Date | Sold / Bought | Shares | Price | Value |
|---|---|---|---|---|---|
| Singhal Priya | Dec 9, 2024 | Sell | 110 | $157.21 | $17,000 |
| Singhal Priya | Sep 3, 2024 | Sell | 431 | $204.22 | $88,000 |
| Singhal Priya | Apr 2, 2024 | Sell | 93 | $213.09 | $20,000 |
| Singhal Priya | Feb 22, 2024 | Sell | 262 | $221.23 | $58,000 |
| Singhal Priya | Feb 16, 2024 | Sell | 108 | $221.49 | $24,000 |
| Rowinsky Eric K | Feb 15, 2024 | Buy | 455 | $222.54 | $100,000 |
| Singhal Priya | Feb 2, 2024 | Sell | 634 | $245.93 | $160,000 |
| Singhal Priya | Dec 11, 2023 | Sell | 110 | $248 | $27,000 |
| Singhal Priya | Sep 5, 2023 | Sell | 431 | $269.43 | $120,000 |
| Singhal Priya | Jul 3, 2023 | Sell | 81 | $282.87 | $23,000 |
| Gregory Ginger | Apr 28, 2023 | Sell | 2,681 | $300 | $800,000 |
| Singhal Priya | Apr 4, 2023 | Sell | 91 | $277.11 | $25,000 |
| Singhal Priya | Mar 28, 2023 | Sell | 568 | $270.06 | $150,000 |
What's the latest insider transaction for Biogen?
The most recent insider transaction for Biogen was conducted by Singhal Priya, who sold 110 shares on December 9, 2024 at a price of $157.21 per share.
Which insider bought the most BIIB stock over the last two years?
Rowinsky Eric K has bought the most BIIB stock in the last 2 years, with a total value of $100,000.
Which insider has sold the most BIIB stock over the last two years?
Gregory Ginger has sold the most BIIB stock in the last 2 years, with a total value of $800,000.
What is the total value of insider transactions for Biogen (BIIB) in the last 2 years?
The total value of insider transactions for Biogen in the last 2 years is negative, amounting to -$1.4M. This suggests that insiders have predominantly sold shares, which could reflect various personal or financial considerations rather than a straightforward outlook on the company's future performance.
How do insider transactions over the last 2 years reflect on Biogen's market confidence?
Over the last 2 years, insider transactions for Biogen have largely consisted of selling shares, which could suggest various personal or financial motivations among insiders. The higher number of sales might require investors to investigate further, considering insiders might have insights or reasons not immediately apparent to the public.
Why is monitoring insider trading activity important for investors?
Monitoring insider trading activity is important because it provides insights into the confidence levels of a company's insiders, such as executives and directors, regarding the company's future prospects. Insider buying can signal optimism, suggesting the stock may be undervalued, while insider selling might raise questions about the stock's upcoming performance. However, it's essential to consider that sales can also occur for personal financial reasons. Insider trading activity is a valuable indicator that, when combined with other data, can help inform investment decisions.
